{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:11:37Z","timestamp":1790395897186,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>This analysis assesses clinical characteristics of patients with refractory chronic cough (RCC) or unexplained chronic cough (UCC) enrolled in a phase 2 study to better understand this patient population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients with RCC\/UCC lasting for\u2009\u2265\u20091\u00a0year and cough severity visual analog scale (VAS) score of\u2009&gt;\u200940\u00a0mm at screening were eligible. Demographics, clinical characteristics, and medical history were collected at baseline. Cough-related measures included cough severity VAS, Cough Severity Diary (CSD), Leicester Cough Questionnaire (LCQ), and a structured cough-trigger questionnaire. Medication history included all medications 30\u00a0days before screening and chronic cough treatments within 1\u00a0year before screening. Data were summarized using descriptive statistics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Patients (<jats:italic>N<\/jats:italic>\u2009=\u2009253; female, 76%; mean age, 60\u00a0years) had severe (mean cough severity VAS, 57.5\u00a0mm) and long-lasting (median duration, 11\u00a0years) cough. The most burdensome self-reported aspects included psychological and social factors (LCQ) and cough frequency and intensity (CSD). Patient-reported triggers were consistent with cough hypersensitivity (e.g., 95% to 96% reported irritation or tickle in throat). Common reported comorbidities included gastroesophageal reflux disease (GERD; 56%), allergic rhinitis (47%), and asthma (30%); 12% of patients had been diagnosed with all 3 conditions. The most common prior medications included inhaled or oral steroids (21%), antihistamines (15%), and antacids (15%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Patients with RCC\/UCC had severe, long-lasting, and burdensome cough with clinical features of cough hypersensitivity. Many patients had been diagnosed with GERD, allergic rhinitis, and asthma but had a persistent cough despite treatment of these conditions.<\/jats:p>\n                <jats:p><jats:bold>Trial registration: <\/jats:bold>ClinicalTrials.gov, NCT02612610; registered November 20, 2015<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00408-021-00437-7","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T11:03:34Z","timestamp":1617793414000},"page":"121-129","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant"],"prefix":"10.1007","volume":"199","clinical-trial-number":[{"clinical-trial-number":"nct02612610","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6135-9610","authenticated-orcid":false,"given":"Alyn H.","family":"Morice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surinder S.","family":"Birring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorcan P.","family":"McGarvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Schelfhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Martin Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi Jin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Muccino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandel R.","family":"Sher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,7]]},"reference":[{"key":"437_CR1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.chest.2017.10.016","volume":"153","author":"RS Irwin","year":"2018","unstructured":"Irwin RS, French CL, Chang AB et al (2018) Classification of cough as a symptom in adults and management algorithms: CHEST Guideline and Expert Panel Report. Chest 153:196\u2013209","journal-title":"Chest"},{"key":"437_CR2","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1183\/09031936.00218714","volume":"45","author":"W-J Song","year":"2015","unstructured":"Song W-J, Chang Y-S, Faruqi S et al (2015) The global epidemiology of chronic cough in adults: a systematic review and meta-analysis. Eur Respir J 45:1479\u20131481","journal-title":"Eur Respir J"},{"key":"437_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0025-6196(11)60967-1","volume":"82","author":"TJ Kuzniar","year":"2007","unstructured":"Kuzniar TJ, Morgenthaler TI, Afessa B et al (2007) Chronic cough from the patient\u2019s perspective. Mayo Clin Proc 82:56\u201360","journal-title":"Mayo Clin Proc"},{"key":"437_CR4","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00408-015-9701-2","volume":"193","author":"SAF Chamberlain","year":"2015","unstructured":"Chamberlain SAF, Garrod R, Douiri A et al (2015) The impact of chronic cough: a cross-sectional European survey. Lung 193:401\u2013408","journal-title":"Lung"},{"key":"437_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1745-9974-3-5","volume":"3","author":"CF Everett","year":"2007","unstructured":"Everett CF, Kastelik JA, Thompson RH et al (2007) Chronic persistent cough in the community: a questionnaire survey. Cough 3:5","journal-title":"Cough"},{"key":"437_CR6","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.rmed.2012.11.018","volume":"107","author":"N Yousaf","year":"2013","unstructured":"Yousaf N, Montinero W, Birring SS et al (2013) The long term outcome of patients with unexplained chronic cough. Respir Med 107:408\u2013412","journal-title":"Respir Med"},{"key":"437_CR7","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12890-017-0496-1","volume":"17","author":"HO Koskela","year":"2017","unstructured":"Koskela HO, L\u00e4tti AM, Purokivi MK (2017) Long-term prognosis of chronic cough: a prospective, observational cohort study. BMC Pulm Med 17:146","journal-title":"BMC Pulm Med"},{"key":"437_CR8","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.alit.2020.03.012","volume":"69","author":"S-Y Kang","year":"2020","unstructured":"Kang S-Y, Song W-J, Won H-K et al (2020) Cough persistence in adults with chronic cough: a 4-year retrospective cohort study. Allergol Int 69:588\u2013593","journal-title":"Allergol Int"},{"key":"437_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.rmed.2018.06.024","volume":"141","author":"JT Good Jr","year":"2018","unstructured":"Good JT Jr, Rollins DR, Kolakowski CA et al (2018) New insights in the diagnosis of chronic refractory cough. Respir Med 141:103\u2013110","journal-title":"Respir Med"},{"key":"437_CR10","doi-asserted-by":"publisher","first-page":"1901136","DOI":"10.1183\/13993003.01136-2019","volume":"55","author":"AH Morice","year":"2020","unstructured":"Morice AH, Millqvist E, Bieksiene K et al (2020) ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J 55:1901136","journal-title":"Eur Respir J"},{"key":"437_CR11","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.jaip.2020.01.054","volume":"8","author":"RS Zeiger","year":"2020","unstructured":"Zeiger RS, Schatz M, Butler RK et al (2020) Burden of specialist-diagnosed chronic cough in adults. J Allergy Clin Immunol Pract 8:1645\u20131657","journal-title":"J Allergy Clin Immunol Pract"},{"key":"437_CR12","doi-asserted-by":"publisher","first-page":"e030945","DOI":"10.1136\/bmjopen-2019-030945","volume":"9","author":"HO Koskela","year":"2019","unstructured":"Koskela HO, L\u00e4tti AM, Pekkanen J (2019) Risk factors for repetitive doctor\u2019s consultations due to cough: a cross-sectional study in a Finnish employed population. BMJ Open 9:e030945","journal-title":"BMJ Open"},{"key":"437_CR13","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.jaip.2019.04.012","volume":"7","author":"L McGarvey","year":"2019","unstructured":"McGarvey L, Gibson PG (2019) What is chronic cough? Terminology. J Allergy Clin Immunol Pract 7:1711\u20131714","journal-title":"J Allergy Clin Immunol Pract"},{"key":"437_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1378\/chest.15-0164","volume":"148","author":"CT French","year":"2015","unstructured":"French CT, Diekemper RL, Irwin RS et al (2015) Assessment of intervention fidelity and recommendations for researchers conducting studies on the diagnosis and treatment of chronic cough in the adult: CHEST Guideline and Expert Panel Report. Chest 148:32\u201354","journal-title":"Chest"},{"key":"437_CR15","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1365-2648.2009.05216.x","volume":"66","author":"M-K Song","year":"2010","unstructured":"Song M-K, Happ MB, Sandelowski M (2010) Development of a tool to assess fidelity to a psycho-educational intervention. J Adv Nurs 66:673\u2013682","journal-title":"J Adv Nurs"},{"key":"437_CR16","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/S2213-2600(18)30150-4","volume":"6","author":"SB Mazzone","year":"2018","unstructured":"Mazzone SB, Chung KF, McGarvey L (2018) The heterogeneity of chronic cough: a case for endotypes of cough hypersensitivity. Lancet Respir Med 6:636\u2013646","journal-title":"Lancet Respir Med"},{"key":"437_CR17","doi-asserted-by":"publisher","first-page":"394","DOI":"10.4168\/aair.2017.9.5.394","volume":"9","author":"WJ Song","year":"2017","unstructured":"Song WJ, Morice AH (2017) Cough hypersensitivity syndrome: a few more steps forward. Allergy Asthma Immunol Res 9:394\u2013402","journal-title":"Allergy Asthma Immunol Res"},{"key":"437_CR18","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1183\/09031936.00218613","volume":"44","author":"AH Morice","year":"2014","unstructured":"Morice AH, Millqvist E, Belvisi MG et al (2014) Expert opinion on the cough hypersensitivity syndrome in respiratory medicine. Eur Respir J 44:1132\u20131148","journal-title":"Eur Respir J"},{"key":"437_CR19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.chest.2017.06.024","volume":"152","author":"CL French","year":"2017","unstructured":"French CL, Crawford SL, Bova C et al (2017) Change in psychological, physiological, and situational factors in adults after treatment of chronic cough. Chest 152:547\u2013562","journal-title":"Chest"},{"key":"437_CR20","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s40520-019-01464-4","volume":"32","author":"G Campi","year":"2020","unstructured":"Campi G, Noale M, Fabbrizzi A et al (2020) The demographic and clinical characteristics of an Italian population of adult outpatients with chronic cough. Aging Clin Exp Res 32:741\u2013746","journal-title":"Aging Clin Exp Res"},{"key":"437_CR21","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.chest.2017.05.038","volume":"152","author":"Y \u00c7olak","year":"2017","unstructured":"\u00c7olak Y, Nordestgaard BG, Laursen LC et al (2017) Risk factors for chronic cough among 14,669 individuals from the general population. Chest 152:563\u2013573","journal-title":"Chest"},{"key":"437_CR22","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1183\/09031936.00217813","volume":"44","author":"AH Morice","year":"2014","unstructured":"Morice AH, Jakes AD, Faruqi S et al (2014) A worldwide survey of chronic cough: a manifestation of enhanced somatosensory response. Eur Respir J 44:1149\u20131155","journal-title":"Eur Respir J"},{"key":"437_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.coph.2015.03.003","volume":"22","author":"SS Birring","year":"2015","unstructured":"Birring SS, Spinou A (2015) How best to measure cough clinically. Curr Opin Pharmacol 22:37\u201340","journal-title":"Curr Opin Pharmacol"},{"key":"437_CR24","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S2213-2600(19)30471-0","volume":"8","author":"JA Smith","year":"2020","unstructured":"Smith JA, Kitt MM, Morice AH et al (2020) Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial. Lancet Respir Med 8:775\u2013785","journal-title":"Lancet Respir Med"},{"key":"437_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1183\/09031936.00101307","volume":"32","author":"A Kelsall","year":"2008","unstructured":"Kelsall A, Decalmer S, Webster D et al (2008) How to quantify coughing: correlations with quality of life in chronic cough. Eur Respir J 32:175\u2013179","journal-title":"Eur Respir J"},{"key":"437_CR26","doi-asserted-by":"publisher","first-page":"175346662091515","DOI":"10.1177\/1753466620915155","volume":"14","author":"A Martin Nguyen","year":"2020","unstructured":"Martin Nguyen A, Bacci E, Dicpinigaitis P et al (2020) Quantitative measurement properties and score interpretation of the cough severity diary in patients with chronic cough. Ther Adv Respir Dis 14:1753466620915155","journal-title":"Ther Adv Respir Dis"},{"key":"437_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/thorax.58.4.339","volume":"58","author":"SS Birring","year":"2003","unstructured":"Birring SS, Prudon B, Carr AJ et al (2003) Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 58:339\u2013343","journal-title":"Thorax"},{"key":"437_CR28","doi-asserted-by":"publisher","first-page":"00012","DOI":"10.1183\/23120541.00012-2021","volume":"7","author":"PV Dicpinigaitis","year":"2021","unstructured":"Dicpinigaitis PV (2021) Prevalence of stress urinary incontinence in women presenting for evaluation of chronic cough. ERJ Open Res 7:00012\u201302021","journal-title":"ERJ Open Res"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-021-00437-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-021-00437-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-021-00437-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T10:05:29Z","timestamp":1628589929000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-021-00437-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["437"],"URL":"https:\/\/doi.org\/10.1007\/s00408-021-00437-7","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"25 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AHM has received consulting fees from Bayer, Bellus, Boehringer Ingelheim, Merck, Pfizer, Proctor & Gamble, and Shionogi; lecture fees from AstraZeneca and Boehringer Ingelheim; and grant support from Afferent, Infirst, Merck, and Proctor & Gamble. SSB has received grants from Merck & Co., Inc.; scientific advisory board and consultancy fees from Bayer, Menlo, Merck & Co., Inc., Patara, Pfizer, and Sanofi; speaker fees from Roche; and grants for travel and subsistence for attendance to scientific meetings from Boehringer Ingelheim. JAS has received grants and personal fees related to the submitted work from Afferent Pharmaceuticals\/Merck & Co., Inc.; grants from Ario Pharma, Bayer, Bellus, GlaxoSmithKline, Menlo, and NeRRe Pharmaceuticals; personal fees from Ario Pharma, Bayer, Bellus, Boehringer Ingleheim, Chiesi, GlaxoSmithKline, Genentech, Menlo, Neomed, and NeRRe Pharmaceuticals; nonfinancial support from Vitalograph; and is a named inventor on a patent, owned by Manchester University NHS Foundation Trust and licensed to Vitalograph Ltd, describing the detection of cough from sound recordings. JAS is also funded by the NIHR Manchester Biomedical Research Centre and a Wellcome Investigator Award and is an NIHR Senior Investigator. LPM has received grants from Afferent Pharmaceuticals\/Merck & Co., Inc., British Heart Foundation, Chiesi, EU Interreg VA Health & Life Science Programme, and NC3Rs; personal fees from Afferent Pharmaceuticals\/Merck & Co., Inc., Applied Clinical Intelligence, and AstraZeneca; grants for travel and subsistence for attendance to scientific meetings from Boehringer Ingelheim, Chiesi, and GlaxoSmithKline; and advisory board\/consultancy fees from Almirall, Boehringer Ingelheim, GlaxoSmithKline, and NAPP. JS, AMN, ZJX, W-CW, and DRM are employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. MRS has received grants and personal fees from Afferent Pharmaceuticals\/Merck & Co., Inc. and is a consultant for AstraZeneca, Bayer, Bellus, NeRRe Therapeutics, and Nocion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in accordance with the ethical standards of the Declaration of Helsinki. Approval of the clinical study (NCT02612610) at each study site was granted by one of the following institutional review boards (IRBs)\/independent ethics committees: the Health Research Authority NRES Committee (Jarrow, UK), Sterling IRB (Atlanta, GA), Western IRB (Puyallup, WA), University of Utah IRB (Salt Lake City, UT), Kaiser Permanente Southern California IRB (Pasadena, CA), St. Luke\u2019s Hospital IRB (Chesterfield, MO), or Mayo Clinic IRB (Rochester, MN).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All patients provided written informed consent before enrollment.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}]}}